Cargando…
FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
Genome editing technologies hold tremendous potential in biomedical research and drug development. Therefore, it is imperative to discover gene editing tools with superior cutting efficiency, good fidelity, and fewer genomic restrictions. Here, we report a CRISPR/Cas9 from Faecalibaculum rodentium,...
Autores principales: | Cui, Zifeng, Tian, Rui, Huang, Zhaoyue, Jin, Zhuang, Li, Lifang, Liu, Jiashuo, Huang, Zheying, Xie, Hongxian, Liu, Dan, Mo, Haiyan, Zhou, Rong, Lang, Bin, Meng, Bo, Weng, Haiyan, Hu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931148/ https://www.ncbi.nlm.nih.gov/pubmed/35301321 http://dx.doi.org/10.1038/s41467-022-29089-8 |
Ejemplares similares
-
The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy
por: Cui, Zifeng, et al.
Publicado: (2021) -
The impact of nucleosome structure on CRISPR/Cas9 fidelity
por: Handelmann, Christopher R, et al.
Publicado: (2023) -
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)